3rd Reporting Aggregate Spend & Sunshine Act Compliance Conference

In an effort to improve transparency in healthcare, provisions of the long deliberated Physician Payment Sunshine Act have officially been passed as part of federal Healthcare Reform. Beginning in 2013, pharmaceutical, biotech and medical device companies are required to track and submit reports on spend associated with physicians across the nation. While the industry awaits specific guidance on implementation of the federal legislation, companies must take action now to ensure that they are prepared to meet the 2013 submission deadline for information related to 2012 spend.

ExL Pharma’s 3rd Reporting Aggregate Spend & Sunshine Act Compliance conference provides attendees with concrete strategies for managing the compliance burden and minimizing risk of reporting aggregate spend under the Sunshine Act. The expert speaking faculty shares best practices for how companies can prepare themselves for federal regulations while meeting additional state requirements to ensure that corporate objectives are simultaneously being met.

Top Reasons To Attend This Conference

• Take-away key strategies for compliance and reporting as attendees and speakers share their knowledge on the latest Sunshine Act provisions.
• Learn practical approaches in preparing smaller pharmaceutical companies and medical device companies for the new regulations by quickly building an aggregate spend program.
• Focus on the components of the regulations and the impact it has on your company, as well as the affect it has on the physicians that you work with.
• Learn directly from your peers as this conference is primary-market driven, with the majority of speakers being from pharmaceutical and medical device companies.